These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12620179)

  • 21. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL; Gleason BL
    Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetic nephropathy. Are the blood pressure values set too low?].
    Zidek W
    MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985
    [No Abstract]   [Full Text] [Related]  

  • 23. Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study.
    Johnson SL; Tierney EF; Onyemere KU; Tseng CW; Safford MM; Karter AJ; Ferrara A; Duru OK; Brown AF; Narayan KM; Thompson TJ; Herman WH
    Diabetes Care; 2006 Aug; 29(8):1733-8. PubMed ID: 16873772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of microalbuminuria in achieving blood pressure goals.
    Duka I; Bakris G
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive agents for prevention of diabetic nephropathy.
    Dressler RL
    Am Fam Physician; 2006 Jul; 74(1):77-9. PubMed ID: 16848380
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetic nephropathy--methods of preventing and inhibiting progression].
    Klinger M
    Przegl Lek; 1995; 52(4):138-40. PubMed ID: 7638360
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diabetes, hypertension and microalbuminuria in primary care].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():33-8. PubMed ID: 14732948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical inquiries. What are the indications for treatment with angiotensin-converting enzyme (ACE) inhibitors in patients with diabetes?
    Loomis LW; Quint A
    J Fam Pract; 2001 Oct; 50(10):842-3. PubMed ID: 11674883
    [No Abstract]   [Full Text] [Related]  

  • 31. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
    Basi S; Lewis JB
    Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
    Folan LA; Tuttle KR
    Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria?
    Sferra L; Kelsberg G; Dodson S; Saseen J
    J Fam Pract; 2004 Jan; 53(1):68-9. PubMed ID: 14709273
    [No Abstract]   [Full Text] [Related]  

  • 37. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
    Dietrich W; Blumenstein M
    MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026
    [No Abstract]   [Full Text] [Related]  

  • 39. [Normoalbuminuria at all costs?].
    Maggio M
    G Ital Nefrol; 2011; 28(4):354. PubMed ID: 21809300
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kidney failure, proteinuria, and diabetic nephropathy].
    Collart F
    Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.